HKEX: 0570 - China Traditional Chinese Medicine Holdings Co. Limited

Yield per half year: -44.93%
Sector: Healthcare

China Traditional Chinese Medicine Holdings Co. Limited

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
8/10
14 35.42 -60.48% 13.89 +0.7518%
P/S 0.9926 7.59 -86.92%
P/BV 0.7515 3.68 -79.61%
P/FCF 23.39 55.3 -57.7%
Ev/Ebitda 8.94 2.91 207.59%
Ev/S 1.11 23.72 -95.34%
Ev/FCF 29.45 63.78 -53.83%
E/P 0.0808 0.0326 147.62%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
5/10
15.1 -11.9 -226.87% 15.91 -5.07%
ROE 6.22 5.19 19.92%
ROA 3.54 3.47 1.92%
ROIC 0 0 0%
ROS 7.09 -11.49 -161.72%
ROCE 0 6.04 -100%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
6/10
2.33 0.7755 200.88% 2.06 +13.54%
Nеt Debt/Ebitda 0.9465 0.0127 7333.78%
Debt/Ratio 0.136 0.1229 10.67%
Debt/Equity 0.6364 0.802 -20.65%
Debt/Net Income 3.92 1.76 123.13%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 5.7 -100% 2.66 -100%
Number of years of dividend growth 0 1.13 -100%
DSI 0.7143 0.5838 22.35%
Average dividend growth -4.12 3.2 -228.71%
Average percentage for 5 years 2.66 4.95 -46.23%
Average percentage for payments 47.19 23.96 96.93%
Difference from average difference in sector -5.7

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
4/10
26.54 28.69 -7.49%
Growth impulse Ebitda in 5 years 1.45 -40.52 -103.58%
Growth impulse Net Income in 5 years -19.07 94.84 -120.11%
Growth impulse FCF in 5 years 65.2 91.41 -28.67%
Growth impulse EPS in 5 years -19.08 -118.14 -83.85%
IP Score
4.57/10

Similar companies

JD Health International Inc.

WuXi Biologics (Cayman) Inc.

Sinopharm Group Co. Ltd.

Hangzhou Tigermed Consulting Co., Ltd

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription